Technical Analysis for XBIT - XBiotech Inc.
|Grade||Last Price||% Change||Price Change|
XBIT closed up 2.87 percent on Friday, January 18, 2019, on 85 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
|Weak or Absent||Up||Up||Up|
|See historical XBIT trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 18||Stochastic Reached Overbought||Strength||0.00%|
|Jan 18||Overbought Stochastic||Strength||0.00%|
|Jan 18||Up 3 Days in a Row||Strength||0.00%|
|Jan 17||20 DMA Support||Bullish||2.87%|
|Jan 17||MACD Bullish Signal Line Cross||Bullish||2.87%|
|Jan 16||20 DMA Support||Bullish||7.21%|
|Jan 15||MACD Bearish Signal Line Cross||Bearish||12.75%|
|Jan 15||20 DMA Support||Bullish||12.75%|
|Jan 15||Wide Bands||Range Expansion||12.75%|
|Jan 14||Bearish Engulfing||Bearish||6.64%|
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
XBiotech, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing True Human monoclonal antibodies for treating various different diseases. Its lead product is Xilonix, which is in II Phase III clinical trials for the treatment of colorectal cancer in the United States and Europe. The company also develops MABp1, a therapeutic antibody, which neutralizes interleukin-1 alpha; and completed a Phase I/II clinical trials for MABp1 as a treatment for cancer. In addition, it investigates MABp1 in clinical trials for other indications, including vascular disease, type II diabetes, acne, and psoriasis. XBiotech, Inc. was founded in 2005 and is headquartered in Austin, Texas.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more XBIT news...
|52 Week High||6.5|
|52 Week Low||2.13|
|200-Day Moving Average||4.2482|
|50-Day Moving Average||4.7598|
|20-Day Moving Average||5.5185|
|10-Day Moving Average||5.659|
|Average True Range||0.4986|
|Chandelier Exit (Long, 3 ATRs )||5.0042|
|Chandelier Exit (Short, 3 ATRs )||6.0358|
|Upper Bollinger Band||6.301|
|Lower Bollinger Band||4.736|
|Percent B (%b)||0.87|
|MACD Signal Line||0.2947|
|Market Cap||216.06 Million|
|Num Shares||35.4 Million|
|Price-to-Earnings (P/E) Ratio||-4.18|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||6.85|
|Resistance 3 (R3)||6.78||6.46||6.73|
|Resistance 2 (R2)||6.46||6.27||6.50||6.68|
|Resistance 1 (R1)||6.28||6.15||6.37||6.35||6.64|
|Support 1 (S1)||5.78||5.77||5.87||5.85||5.56|
|Support 2 (S2)||5.46||5.65||5.50||5.52|
|Support 3 (S3)||5.28||5.46||5.48|
|Support 4 (S4)||5.35|